Similar articles

• Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus.

  Bril F, Cusi K. Bril F, et al. Endocrinol Metab Clin North Am. 2016 Dec;45(4):765-781. doi: 10.1016/j.ecl.2016.06.005. Epub 2016 Oct 4. Endocrinol Metab Clin North Am. 2016. PMID: 27823604 Review.
• Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity.

  Kvitne KE, Åsberg A, Johnson LK, Wegler C, Hertel JK, Artursson P, Karlsson C, Andersson S, Sandbu R, Skovlund E, Christensen H, Jansson-Löfmark R, Hjelmesaeth J, Robertsen I. Kvitne KE, et al. Clin Transl Sci. 2022 Nov;15(11):2685-2696. doi: 10.1111/cts.13394. Epub 2022 Sep 8. Clin Transl Sci. 2022. PMID: 36037309 Free PMC article.
• [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].

  Liu Y, Cheng F, Luo YX, Hu P, Ren H, Peng ML. Liu Y, et al. Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):285-290. doi: 10.3760/cma.j.issn.1007-3418.2017.04.010. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28494548 Chinese.
• The structure and characterization of human cytochrome P450 8B1 supports future drug design for nonalcoholic fatty liver disease and diabetes.

  Liu J, Carlson HA, Scott EE. Liu J, et al. J Biol Chem. 2022 Sep;298(9):102344. doi: 10.1016/j.jbc.2022.102344. Epub 2022 Aug 6. J Biol Chem. 2022. PMID: 35944583 Free PMC article.
• [Non-alcoholic fatty liver disease and type 2 diabetes mellitus. I. Pathogenesis].

  Pár A, Wittmann I, Pár G. Pár A, et al. Orv Hetil. 2022 May 22;163(21):815-825. doi: 10.1556/650.2022.32479. Print 2022 May 22. Orv Hetil. 2022. PMID: 35598211 Review. Hungarian.